VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

Jun 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-06-11

Reporting Person: Horton Kenneth L (EVP & Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-11	Common Stock	A	9667	$0.01	Acquired	9667	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-11	Employee Stock Option (right to buy)	$55.83	A	72000	Acquired	2022-06-10	Common Stock (72000)	Direct

Footnotes

F1: Restricted stock grant vesting in four annual installments beginning on 6/11/2013.

F2: The option vests in 16 quarterly installments beginning on 9/11/2012.